Pharmaceutical composition containing cow urine distillate and an antibiotic

US 6410059 B1
Abstract
A pharmaceutical composition comprising an antibiotic and cow urine distillate in an amount
effective to enhance antimicrobial effect of the antibiotic is disclosed. The antibiotic can be an
antifungal agent. The antibiotic can be a quinolone or a fluoroquinolone. The antifungal agent
can be azoles, clotrimazole, mystatin or amphotericin.

Publication number
US6410059 B1
Publication type Grant
Application number US 09/726,307
Publication date 25 Jun 2002
Filing date 1 Dec 2000
Priority date 20 Oct 2000
Fee status Paid
Also published as US6896907, US7235262, US20020164378, US20050100610
Inventors Suman Preet Singh Khanuja, 14 More
Original Assignee Council Of Scientific And Industrial Research
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (2), Referenced by (3), Classifications (9), Legal Events (5)
External Links: USPTO, USPTO Assignment, Espacenet

Description
This application claims priority under 35 U.S.C. 119 and/or 365 to 60/241,842 filed in the
United States on Oct. 20, 2000 ; the entire content of which is hereby incorporated by reference.
FIELD OF THE INVENTION
The invention relates to an absolutely novel use of cow urine distillate as activity enhancer and
availability facilitator for bioactive molecules including anti-infective and anti-cancer
agents. The molecules which express any activity in form of either inhibiting or promoting a
biological function have been referred in this invention as bioactive molecule e.g. antibiotics,
drugs, nutraceuticals, cardiovascular, hepatoprotective, neuro-tonics etc. The present invention
has direct implication in drastically reducing the dosage of antibiotics, drugs and anti-cancer
agent while increasing the efficiency of absorption of bioactive molecules.